CTMX CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 1 day ago Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4%… CytomX Therapeutics, Inc. (CTMX) Reports Full Year 2025 Earnings 2 days ago Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4%…